1. Introduction {#sec1}
===============

Epidemiological studies have identified a link between obesity and psychiatric disorders, particularly those involving stress-related depressive symptoms [@bib1; @bib2; @bib3; @bib4]. The well-documented effects of glucocorticoids to promote fuel mobilization and insulin secretion led several groups to hypothesize that dysregulation of the neuroendocrine stress axis contributes to the development of metabolic and cardiovascular diseases [@bib5; @bib6; @bib7]. However, evidence from some prospective studies supports the idea that obesity promotes risk of depression, but not the reverse [@bib8; @bib9]. HPA axis hyperactivity in obese patients is likely due to alterations in central signaling pathways, as they exhibit normal pituitary sensitivity to negative feedback from glucocorticoids [@bib10]. Progress in elucidating the molecular and neuronal players that could mediate the effects of signals of metabolic status on stress responses have been described in several recent reviews [@bib11; @bib12; @bib13].

The neuroendocrine stress response axis is strongly influenced by the availability of food and energy stores. Basal activity is lowest and stress responsivity highest in the energy replete state [@bib5]. Conversely, fasting is associated with elevated basal levels of CORT and decreased responsivity to stressors [@bib5; @bib14]. ARH neurons sense nutrient and hormone signals of energy status [@bib15] and project to critical nodes of the HPA axis [@bib16], and thus are well-positioned to serve as the conduit for metabolic influences on stress responses. Inhibition of the activity of the mediobasal hypothalamus (MBH) produces a fasting-like pattern of HPA axis activity in fed animals, with no effect on stress responses in the fasted state [@bib14], consistent with idea that the MBH provides signals of positive energy balance to the HPA axis.

There are several hormone signals of positive energy balance that are sensed by MBH neurons and are also reported to modulate stress responses, including leptin, glucagon-like peptide-1 and cholecystokinin (reviewed in [@bib13]). However, conflicting results from studies using gain- and loss-of function approaches have hindered progress toward elucidating the underlying mechanism. Whereas central administration of these hormones has been reported to activate neurons expressing c*orticotropin-releasing hormone (*CRH, also known as CRF) and promote CORT release [@bib17; @bib18; @bib19], loss of function mutations in the corresponding receptors are associated with increased HPA tone, consistent with an inhibitory effect of these hormones on stress responses [@bib20; @bib21; @bib22]. Differences in the type, severity and duration of the experimental stressors applied by different groups likely contribute to these apparent inconsistencies. In addition, most studies lack the temporal resolution to distinguish processes associated with the initiation of the stress response from those that are activated to provide negative feedback. Finally, it is possible that different populations in the brain and periphery that are activated by these signals could influence different aspects of the stress response.

Insulin is reciprocally regulated with CORT during stress, consistent with the idea that insulin normally provides inhibitory tone to HPA axis [@bib5]. However, as is the case for other gain of function studies, there are studies that report effects of brain insulin to suppress [@bib23] and enhance [@bib24] the neuroendocrine stress response. As there is a positive correlation between HPA axis responsivity and homeostasis insulin resistance index (HOMA-IR) in obese patients [@bib7; @bib25], we set out to examine whether impaired central insulin signaling in lean animals impacts stress axis function. To this end, we utilized the *Nkx2.1-Cre* transgene to broadly disrupt signaling through the insulin receptor (InsR) in the hypothalamus [@bib26; @bib27; @bib28]. After discovering that the resulting IR^Nkx2.1^ KOs have impaired negative feedback to the HPA axis, we generated additional conditional InsR knockouts to assess the contribution of *Agrp-Cre*-expressing neurons in the ARH (IR^Agrp^ KOs) and *Sim1-Cre*-expressing neurons in the PVH and amygdala (IR^Sim1^ KOs) to this phenotype.

2. Material and methods {#sec2}
=======================

2.1. Animal husbandry {#sec2.1}
---------------------

Mice were maintained in a temperature- (22 ± 1 °C) and light- (12:12h light dark cycle, lights on at 7pm and off at 7pm) controlled environment. Pups were weaned on post-natal day 21. Unless otherwise noted, mice had *ad libitum* access to chow (9% calories from fat, 5058 Mouse diet 20, Labdiet) and water until the time of sacrifice. Male mice older than 8 weeks of age were used in all studies. Since female sex hormones are known to influence activity of the HPA axis [@bib29], we limited our analysis in this study to male mice. All procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee at Columbia University Health Sciences Division.

2.2. Generation of IR^Nkx2.1^, IR^Sim1^ and IR^AgRP^ KO mice {#sec2.2}
------------------------------------------------------------

To generate conditional knockouts of *Insr* in the hypothalamus, we crossed the *Nkx2.1-Cre* driver line (C57BL/6J-Tg(Nkx2-1-Cre)2Sand/J, provided by S. Anderson, Weill Cornell Medical College) [@bib27] to mice homozygous for a floxed allele of *Insr* (B6.129S4(FVB)-*Insr*^*tm1Khn*^/J) [@bib26] to generate *Nkx2.1-cre;Insr*^*fl/fl*^ mice (IR^Nkx2.1^ KO). *Sim1-Cre;Insr*^*fl/fl*^ (IR^Sim1^ KO) and *Agrp-Cre;Insr*^*fl/fl*^ (IR^AgRP^ KO) mice were generated by a similar mating scheme using *Sim1-Cre* (B6.FVB(129X1)-Tg(Sim1-cre)1Lowl/J) [@bib30] and *Agrp-Cre* (Agrp^tm1(cre)Lowl^) [@bib31] drivers, respectively (provided by Brad Lowell, Beth Israel Deaconness Medical Center). *Insr*^*fl/fl*^ littermates served as controls in all studies. To avoid confounding effects of estrus cyclicity on the HPA axis [@bib32], we performed all analyses in males. Mouse genotypes were assessed by PCR on genomic DNA from tail tips using the following primers: *Cre*: 5′ GCGGTCTGGCAGTAAAAACTATC 3' (forward), 5′ GTGAAACAGCATTGCTGTCACTT 3' (reverse); *Insr*: 5′ TGCACCCCATGTCTGGGACCC 3' (forward), 5′ GCCTCCTGAATAGCTGAGACC 3' (reverse).

2.3. Measurement of serum corticosterone levels {#sec2.3}
-----------------------------------------------

We collected serum from tail bleeds on minimally-stressed animals between 10am and noon (AM samples) or 6--7pm (PM samples), or at 10am after an overnight (14--16 h) fast with *ad libitum* access to drinking water. Blood was clotted at room temperature for one hour and centrifuged to isolate serum. Serum was stored at −20 °C until assessed by CORT radioimmunoassay (MP Biomedicals) or Rat/Mouse CORT ELISA (Alpco).

2.4. Restraint stress response and dexamethasone suppression test {#sec2.4}
-----------------------------------------------------------------

We restrained mice individually in a 50-ml falcon tube for 30 min. We collected tail blood samples at 0, 30 (end of restraint), and 60 min (30 min after restraint) after the beginning of a restraint. For the dexamethasone (DEX) suppression test, we injected mice with saline or DEX (0.1 mg/kg, i.p.) 60 min before a 60 min-long restraint session. We collected tail blood at baseline (before the saline/DEX injections), immediately before restraint (60 min after the saline/DEX injections), at the end of the 60 min restraint period, and 30 min after the end of restraint. We collected and analyzed CORT levels in serum samples as described above.

2.5. Preservation of hypothalamus and pituitary {#sec2.5}
-----------------------------------------------

At the time of sacrifice, animals were anesthetized with 2.5% Avertin, 0.02 ml/g i.p., before cervical dislocation. Hypothalamus (whole hypothalamus, PVH, or median eminence) and pituitary were harvested within 5 min of the avertin injection, and snap-frozen in liquid nitrogen. PVH was dissected out bilaterally from the anterior part (1 mm-thick coronal section) of the hypothalamus and median eminence was dissected from the posterior part (2 mm-thick coronal section) of the basal hypothalamus.

2.6. Quantitative RT-PCR {#sec2.6}
------------------------

For IR^Nkx2.1^ KO and IR^AgRP^ KO mice, we isolated total RNA from fresh-frozen hypothalamus and pituitary using the RNeasy Plus Universal Kit (Qiagen) and synthesized cDNA using the Transcriptor First Strand cDNA Synthesis kit (Roche). We used a LightCycler 480 SYBR Green I Master System (Roche) in quantitative PCR experiments. We normalized the expression of target genes against *Beta actin*. For IR^Sim1^ KO mice, we extracted RNA using the ARCTURUS Picopure RNA Isolation Kit and performed quantitative PCR in an ABI-PRISM 7900 HT Sequence Detection system using fluorogenic Taqman probes specific for the target genes (Applied Biosystems).

Primer Sequences:

*B. actin* (*β-actin*): 5′ CGCCACCAGTTCGCCAT 3' (forward), 5′ CTTTGCACATGCCGGAGC 3′ (reverse); *Corticotropin-releasing hormone* (*Crh*): 5′ AGGAGGCATCCTGAGAGAAGT 3' (forward), 5′ CATGTTAGGGGCGCTCTC 3′ (reverse); *Arginine vasopressin* (*Avp*): 5′ ACTACCTGCCCTCGCCCTGC 3′ (forward), 5′ GCCACGCAGCTCTCGTCGCT 3′ (reverse); *Glucocorticoid receptor (Gr)*: 5′ ACTTCGCAGGCCGCTCAGTGTT 3′ (forward), 5′ TGGTCCCGTTGCTGTGGAGGAGC 3′ (reverse); *Pro-opiomelanocortin* (*Pomc*): 5′ GCAACCTGCTGGCTTGCATCCG 3′ (forward), 5′ CCGAAGCGGTCCCAGCGGAA 3′ (reverse); *Neuropeptide Y (Npy)*: 5′ TCCGCTCTGCGACACTACAT 3′ (forward), 5′ GGAAGGGTCTTCAAGCCTTGTT 3′ (reverse); *Agouti-related peptide (Agrp)*: 5′ GCAATGTTGCTGAGTTGTGT 3′ (forward), 5′ GACTTAGACCTGGGAACTCTG 3′ (reverse).

2.7. Hypothalamic peptide levels {#sec2.7}
--------------------------------

Hypothalamic and median eminence AVP and corticotropin releasing hormone (CRH, also known as CRF) levels were measured with Vasopressin \[Arg8\] Chemiluminescent EIA (Phoenix Pharmaceuticals) and Corticotropin Releasing Factor Chemiluminescent EIA (Phoenix Pharmaceuticals) kits, respectively. ACTH levels were measured by RIA in the lab of Sharon Wardlaw, as previously described [@bib33].

2.8. Behavioral tests {#sec2.8}
---------------------

All behavioral tests were performed between 10am and 2pm.

Open Field Test (OF): After one-hour acclimation to the testing room, we recorded the activity of each mouse in the open field arena for 30 min. We calculated the total distance traveled, and ratio of time spent in the periphery and center of the field; reduced central activity is considered to be an indicator of increased anxiety [@bib34].

Marble Burying Test (MB): We placed each mouse in a cage filled with 4--5 cm of wood chip bedding, and placed 12 marbles, evenly spaced, on top of the bedding. We recorded the number of marbles buried in the bedding within a 20-minute period. An increase in the number of marbles buried is used as an indicator of anxiety- and obsessive-compulsive-disorder-like behavior [@bib35]. We compared marble burying behavior at baseline and one hour after an i.p. injection with 50 μl saline (stress condition).

Stress-Induced Hyperthermia Test (SIH): Stress associated with handling and insertion of a rectal temperature probe thermometer (Thermoworks) causes an increase in core body temperature, an anxiety response that is suggested to be mediated in part by the effects of CORT to increase sympathetic tone [@bib36]. We measured body temperature at baseline and 60 min after stress.

Novelty Suppressed Feeding Test (NSF): After an overnight fast, we placed each mouse in a brightly lit box (30 cm × 40 cm) with bedding on the floor and an accessible food pellet tied down to a circle of Whatman paper in the center of the box. We recorded the time it took an animal to enter the brightly lit center of the arena and to bite the food pellet. Increased latency to feed in a novel environment is considered to be an indicator of anxiety-like behavior [@bib37].

Forced swimming test (FST): We placed mice individually in beakers (46 cm tall × 32 cm in diameter) containing 23--25 °C water 30 cm deep. We conducted two swim sessions between 12:00 and 18:00 h: an initial 6-minute pretest followed 24 h later by a 6-minute test. We monitored and videotaped mice while swimming and recorded the amount of time immobile. Increased immobility is considered to be an indicator of depressive behavior [@bib38].

2.9. Glucose homeostasis {#sec2.9}
------------------------

Baseline glucose levels measurements and glucose tolerance test were performed as previously described [@bib39].

2.10. Statistics {#sec2.10}
----------------

Data are presented as group mean ± SEM. We performed statistical comparisons between groups using a one-way ANOVA, followed by a post-hoc Bonferroni correction. We considered a *P* value of 0.05 or less to be statistically significant.

3. Results {#sec3}
==========

3.1. Diminished InsR signals in *Nkx2.1*-expressing neurons leads to HPA axis hyperactivity {#sec3.1}
-------------------------------------------------------------------------------------------

To explore the possibility that central insulin signals modulate the HPA axis, we assessed the consequences of disrupting InsR signals in *Nkx2.1*-expressing neurons in the forebrain on CORT levels at baseline and in response to psychological and physiological stress. We did not observe a difference between IR^Nkx2.1^ KO and control males in the morning ([Figure 1](#fig1){ref-type="fig"}A), at the nadir of circadian fluctuations in serum CORT levels [@bib40]. CORT levels were approximately 31% and 56% higher in IR^Nkx2.1^ KO males in the evening and in response to fasting, respectively; however, these differences did not reach significance ([Figure 1](#fig1){ref-type="fig"}A). Control and IR^Nkx2.1^ KO males exhibited similar CORT levels at the end of a 30-minute restraint period, but CORT levels 30 min after release from restraint were ∼17% higher in IR^Nkx2.1^ KOs ([Figure 1](#fig1){ref-type="fig"}B). Since mice carrying the *Nkx2.1-Cre* transgene alone did not show an overall change in response to restraint when compared to wild-type animals (data not shown), the altered stress response in IR^Nkx2.1^ KOs can be attributed to the loss of InsR signals.

As the neuroendocrine response to restraint was elevated in IR^Nkx2.1^ KOs, we next performed a dexamethasone (DEX)-suppression test to determine whether the deficit in negative feedback occurs at the level of the pituitary. Saline-injected IR^Nkx2.1^ KO males exhibited a 51% increase in CORT levels as compared to controls at the end of the 60 min restraint period ([Figure 2](#fig2){ref-type="fig"}A) and a 14% increase in stress responsivity ([Figure 2](#fig2){ref-type="fig"}C). IR^Nkx2.1^ KO males were sensitive to DEX suppression ([Figure 2](#fig2){ref-type="fig"}B), supporting the idea that negative feedback to the HPA axis via the pituitary is not impaired.

3.2. Altered expression of HPA axis components in IR^Nkx2.1^ KOs {#sec3.2}
----------------------------------------------------------------

To identify the sites of diminished InsR signals that contribute to HPA axis hyperactivity in IR^Nkx2.1^ KO mice, we evaluated gene expression and peptide levels of several major HPA axis components in the hypothalamus, median eminence (ME) and pituitary at baseline, the end of the 30-minute restraint period, and 30 min after restraint ([Figure 3](#fig3){ref-type="fig"}A). Baseline levels of *Avp* mRNA expression ([Figure 3](#fig3){ref-type="fig"}F) and AVP protein levels in the ME ([Figure 3](#fig3){ref-type="fig"}C) were significantly increased by 53% and 18%, respectively, in IR^Nkx2.1^ KO males. Conversely, baseline levels of pituitary *Pomc* expression were 40% lower ([Figure 3](#fig3){ref-type="fig"}G) and adrenocorticotropic hormone (ACTH) protein levels in the pituitary trended lower ([Figure 3](#fig3){ref-type="fig"}D) in IR^Nkx2.1^ KO males. At baseline, hypothalamic expression of *Crh*, *Gr*, *Pomc*, *Npy* and *Agrp* mRNA, CRH protein levels in the ME, and pituitary expression of *Gr* were similar between IR^Nkx2.1^ KO males and controls ([Figure 3](#fig3){ref-type="fig"}). At the end of the restraint period, we found that *Gr* expression was 30% lower in the hypothalamus ([Figure 3](#fig3){ref-type="fig"}H), but increased in the pituitary of IR^Nkx2.1^ KOs ([Figure 3](#fig3){ref-type="fig"}I), consistent with a centrally-mediated deficit in negative feedback to the HPA axis [@bib41]. Expression of hypothalamic *Avp* and pituitary *Pomc* were significantly different in IR^Nkx2.1^ KOs 30 min after release from restraint, but the changes were in the opposite direction as had been observed at baseline ([Figure 3](#fig3){ref-type="fig"}F--G).

3.3. Increased anxiety-like behaviors in IR^Nkx2.1^ KO males following stress {#sec3.3}
-----------------------------------------------------------------------------

In light of the observed HPA axis hyperactivity in IR^Nkx2.1^ KO males, we evaluated their performance in a series of neuro-behavioral tests. We used open field (OF), marble burying (MB), stress-induced hyperthermia (SIH) and novelty suppressed feeding (NSF) tests to measure anxiety-like behaviors [@bib42]. To evaluate depressive-behavior, we assessed learned helplessness in a forced swim test (FST) [@bib38].

IR^Nkx2.1^ KO males exhibited reduced locomotor activity after 20 min in the OF, but not at earlier timepoints ([Figure 4](#fig4){ref-type="fig"}A, left panel). The decrease in locomotor activity observed at later timepoints was not associated with fewer entries to the center of the field ([Figure 4](#fig4){ref-type="fig"}A, right panel). Marble burying behavior was the same in IR^Nkx2.1^ KO and control males at baseline, but was roughly 50% higher in IR^Nkx2.1^ KOs in response to stress (5 ± 1 control vs. 8 ± 1 KO, *P* \< 0.05)([Figure 4](#fig4){ref-type="fig"}B). Similarly, core body temperature was not different at baseline, but was roughly 0.3 °C higher in IR^Nkx2.1^ KO males after stress (36.6 ± 0.1 control vs. 36.9 ± 0.1 KO, *P* \< 0.05) ([Figure 4](#fig4){ref-type="fig"}C). The latency to feed in the NSF test tended to be higher in IR^Nkx2.1^ KO males as compared to controls, although this difference did not reach significance ([Figure 4](#fig4){ref-type="fig"}D). Finally, time spent immobile in the FST, an indicator of depressive-like behavior in mice, was not altered in IR^Nkx2.1^ KO males ([Figure 4](#fig4){ref-type="fig"}E). In summary, performance of IR^Nkx2.1^ KO males was the same as controls at baseline, but was increased following exposure to stress.

3.4. HPA axis function is not altered in IR^Sim1^ KO males {#sec3.4}
----------------------------------------------------------

Since we observed increased AVP protein levels in the ME and *Avp* mRNA expression in the hypothalamus of IR^Nkx2.1^ KO males, we explored whether InsR actions directly on AVP neurons could be responsible. To this end, we assessed neuroendocrine and molecular correlates of HPA axis responses in IR^Sim1^ KO males, in which InsR signaling is disrupted in *Sim1*-expressing cells in the PVH [@bib30]. Adult IR^Sim1^ KO males exhibited similar body weights and fed glucose levels as control littermates ([Figure 5](#fig5){ref-type="fig"}A--B). Serum CORT levels at baseline and in response to 30 min restraint were also not altered in IR^Sim1^ KO males ([Figure 5](#fig5){ref-type="fig"}C--D). IR^Sim1^ KOs exhibited increased *Avp* expression in the PVH and decreased *Agrp* expression in the ARH at baseline, although these differences did not reach significance ([Figure 5](#fig5){ref-type="fig"}E). These changes were in the same direction as those observed in IR^Nkx2.1^ KOs ([Figure 3](#fig3){ref-type="fig"}F,J). On the other hand, *Pomc* expression in the hypothalamus was significantly increased at baseline in IR^Sim1^ KOs ([Figure 5](#fig5){ref-type="fig"}E), while it was not changed in IR^Nkx2.1^ KOs ([Figure 3](#fig3){ref-type="fig"}J). *Pomc* and *Gr* expression in the pituitary were not significantly altered in IR^Sim1^ KOs as compared to controls ([Figure 5](#fig5){ref-type="fig"}F). In summary, our analyses are consistent with the idea that InsR signals in Sim1 neurons do not exert a major influence on HPA axis responsiveness, although we cannot exclude a minor contribution from these neurons.

3.5. IR^AgRP^ KO mice exhibit reduced AVP levels at baseline {#sec3.5}
------------------------------------------------------------

As stress is reported to increase and insulin is reported to decrease ARH expression of *Npy* and *Agrp* [@bib43; @bib44; @bib45], we next examined the consequences of disrupting InsR signals in *Agrp*-expressing neurons on HPA axis responsiveness. At 13 weeks of age, body weight, fed glucose levels, and glucose tolerance in IR^AgRP^ KO males were similar to control littermates ([Figure 6](#fig6){ref-type="fig"}A--C). Serum CORT levels at baseline and at the end of the 30 min restraint period were also not changed in IR^AgRP^ KO males ([Figure 6](#fig6){ref-type="fig"}D--E). In contrast to what we observed in IR^Nkx2.1^ KO males, IR^AgRP^ KO males exhibited a 25% decrease in CORT response 30 min after release from restraint, although this difference did not reach significance (Controls 41.5 ± 3.9 vs. IR^AgRP^ KOs 31.2 ± 5, *P* = 0.07)([Figure 6](#fig6){ref-type="fig"}E). Consistent with decreased HPA axis responsivity, baseline AVP protein levels in the ME were significantly lower ([Figure 6](#fig6){ref-type="fig"}F) and *Avp* mRNA expression in the hypothalamus trended lower in IR^AgRP^ KO mice ([Figure 6](#fig6){ref-type="fig"}G). In addition, baseline pituitary *Pomc* mRNA levels were increased in IR^AgRP^ KO males, while *Gr* was not changed ([Figure 6](#fig6){ref-type="fig"}H). Together, these findings support the idea that diminished InsR signals in AgRP/NPY neurons results in decreased AVP tone and a trend toward reduced HPA axis responsiveness, the opposite of the phenotype produced by widespread disruption of InsR signals in *Nkx2.1-Cre*-expressing neurons in the forebrain.

4. Discussion {#sec4}
=============

4.1. Impaired negative feedback to HPA axis in IR^Nkx2.1^ KO males {#sec4.1}
------------------------------------------------------------------

Our data support the hypothesis that insulin signaling in the hypothalamus modulates negative feedback to the HPA axis following stress. *Nkx2.1-Cre*-mediated disruption of InsR signaling in the hypothalamus, as well as ventral forebrain-derived neuronal subpopulations in the cortex and amygdala [@bib27; @bib28; @bib39], did not affect plasma CORT levels at baseline or during restraint stress, but delayed the return to baseline ([Figure 1](#fig1){ref-type="fig"}B). Similarly, behaviors assessed over a short time period (i.e. NSF, FST) were not altered in IR^Nkx2.1^ KOs, while modest but significant effects were observed in assays lasting 20 min or more (i.e. OF, MB, SIH) ([Figure 4](#fig4){ref-type="fig"}). Pituitary *Gr* expression and the ability of the synthetic glucocorticoid dexamethasone to suppress stress-induced activation of the HPA axis were not altered in IR^Nkx2.1^ KOs ([Figures 2C and 3I](#fig2 fig3){ref-type="fig"}), suggesting that the pituitary response to stress is not impaired [@bib46]. These observations are consistent with the idea that InsR signals in *Nkx2.1-Cre*-expressing neurons normally act to provide negative feedback to the HPA axis. This idea is also supported by reports that intranasal administration of insulin lowers stress-induced, but not basal, HPA axis responsiveness in humans [@bib23].

The most prominent change in central components of the HPA axis in IR^Nkx2.1^ KOs was increased *Avp* expression in the hypothalamus and AVP protein released into the median eminence at baseline ([Figure 3](#fig3){ref-type="fig"}). Elevated basal AVP levels are also observed in rodents exposed to chronic stress [@bib47; @bib48] and in patients with major depression [@bib49; @bib50]. It has been proposed that this adaptation maintains HPA axis responsiveness in the face of high circulating glucocorticoid levels during chronic stress [@bib51]. However, it is not clear whether increased AVP in IR^Nkx2.1^ KOs is a direct consequence of diminished hypothalamic InsR signaling, or a secondary response to chronic perturbations in the stress axis. In either case, the failure to observe increased AVP to a similar degree in IR^Sim1^ KOs ([Figure 5](#fig5){ref-type="fig"}) argues against a major role for direct effects of insulin on CRH/AVP neurons in the PVH, although a minor contribution cannot be ruled out.

4.2. HPA axis phenotypes of IR^Agrp^ KO males are in opposite direction as those observed in IR^Nkx2.1^ KOs {#sec4.2}
-----------------------------------------------------------------------------------------------------------

NPY and AgRP have been reported to activate CRH neurons *in vivo* and *in vitro* [@bib52; @bib53], while insulin blunts stress-induced increases in NPY levels [@bib43; @bib54] and inhibits NPY/AgRP neuronal activity [@bib55]. Based on these reports, we predicted that a reduction in inhibitory InsR-mediated inputs to AgRP/NPY neurons would lead to heightened stress responses in IR^Agrp^ KOs. Thus, our finding that IR^Agrp^ KOs exhibit decreased AVP and a trend toward a suppressed HPA axis response was the opposite of the expected result ([Figure 6](#fig6){ref-type="fig"}). Consistent with our observations, mice overexpressing an *Agrp* transgene and global knockouts of *Melanocortin receptor 4* also exhibit normal CORT at baseline, but a blunted response to restraint stress [@bib56; @bib57; @bib58]. The possibility that activation of AgRP neurons can act to dampen HPA responses to psychological stress is also supported by the observation that stress-induced increases in *Npy*/*Agrp* occur after the rise in CORT levels and *Pomc* expression [@bib45; @bib59]. Differences in the timing and/or concentration of exposure to AgRP/NPY following restraint tests in genetic models versus central injections of AgRP/NPY compounds could underlie discordant effects on HPA axis activity. If our hypothesis is correct, activation of AgRP/NPY neurons under conditions of limited nutrient availability could promote survival by limiting stress-induced mobilization of fuels [@bib60].

4.3. Possible sources of impaired InsR signals that contribute to HPA axis hyperactivity in IR^Nkx2.1^ KOs {#sec4.3}
----------------------------------------------------------------------------------------------------------

As *Agrp-Cre-* and *Nkx2.1-Cre*-mediated disruption of InsR signaling produce opposite effects on HPA-axis related endpoints, the loss of InsR signals in AgRP/NPY neurons cannot explain the phenotype observed in IR^Nkx2.1^ KOs. Neurons in the dorsomedial hypothalamus are marked by an *Nkx2.1-Cre* linage trace [@bib39], send heavy projections to the PVH [@bib16] and modulate HPA axis activity [@bib61; @bib62] ([Figure 7](#fig7){ref-type="fig"}). However, the lack of information about electrophysiological responses of DMH neurons to insulin and conflicting reports that DMH neurons provide excitatory [@bib61; @bib63] and inhibitory [@bib62] inputs to the HPA axis, hinder the formulation of a hypothesis about the precise mechanism of action. In theory, InsR signaling in ARH POMC neurons could also modulate HPA responses, although projections from these neurons to the neuroendocrine PVH are much sparser than AgRP projections [@bib64; @bib65]. Unfortunately, efforts to explore the possible contribution of InsR in POMC neurons using *Pomc-Cre*-mediated recombination are complicated by the fact that signaling in pituitary corticotrophs would also be impacted.

5. Conclusions {#sec5}
==============

There is a high degree of comorbidity of metabolic and psychological disorders, and the severity of depressive symptoms is correlated with insulin resistance [@bib1; @bib3; @bib4]. Our findings support the idea that InsR signaling in hypothalamic neurons provides an important source of crosstalk between energy status and stress reactivity. InsR signaling in AgRP/NPY neurons appears to promote AVP release, while signaling in an unidentified population likely acts in an opposing fashion. Identification of the latter cell type is an important area for future research, because elevated AVP is thought to contribute to depressive disorders [@bib66].

Conflicts of interest {#appsec1}
=====================

The authors do not have any conflicts of interest.

We thank the Columbia Diabetes and Endocrinology Research Center Animal Phenotyping Core for help with metabolic cages (P30 DK63608); Sharon Wardlaw (Columbia University) for assistance with CORT assays; Rene Hén for guidance with behavioral assays; Domenico Accili (Columbia University) for *Insr* floxed mice; S. Anderson (Weill Cornell Medical College) for *Nkx2.1-Cre* mice; Joel Elmquist (UT Southwestern) and Brad Lowell (Beth Israel Deaconness) for *Agrp-Cre* mice. This work was supported by R01 DK089038 (LMZ).

![**Loss of hypothalamic InsR signals in Nkx2.1 neurons resulted in increased CORT response to restraint**. (**A**) Baseline (AM), peak (PM), and fasting (fasted) serum CORT levels in adult males; *n* ≥ 7 for all groups at all time points. (**B**) Serum CORT levels during a restraint test (baseline, at the end of restraint (the period of restraint is indicated by a grey box), and 30 min after restraint) in adult males; *n* ≥ 12 for IR^Nkx2.1^ KO and controls at all time points. (**B**) \**P* \< 0.05 control versus IR^Nkx2.1^ KO.](gr1){#fig1}

![**Normal response of IR**^**Nkx2.1**^**KOs to dexamethasone-suppression test**. (**A**) Change in serum CORT levels from baseline in saline-treated adult males (the period of restraint is indicated by a grey box) and 30 min after restraint; *n* ≥ 5 for all groups at all time points. (**B**) Change in serum CORT levels from baseline in dexamethasone (DEX)-treated adult males; *n* ≥ 5 for all groups at all time points. (**C**) Area under the curve for CORT levels in saline- and DEX-treated adult males. \**P* \< 0.05 control versus IR^Nkx2.1^ KO.](gr2){#fig2}

![**Altered gene expression of HPA axis components at baseline and during restraint test in IR**^**Nkx2.1**^**KOs**. (**A**) Key components of HPA axis (black text) that release hormones/neuropeptides (red text) and express genes (green text) assessed in our studies. (**B**) CRH and (**C**) AVP protein levels in the median eminence. (**D**) ACTH protein levels in the pituitary. (**E**) *Crh* and (**F**) *Avp* mRNA expression levels in the hypothalamus at baseline, at the end of restraint (30 min), and 30 min post-restraint; *n* ≥ 5 for all groups at all time points. (**G**) *Pomc* mRNA in the pituitary; *n* ≥ 4 for all groups at all time points. (**H**) Hypothalamic and (**I**) pituitary *Gr* mRNA; *n* ≥ 4 for all groups at all time points. (**J**) Baseline mRNA levels of *Pomc*, *Npy*, and *AgRP* in the hypothalamus of male IR^Nkx2.1^ KO and controls; *n* ≥ 4 for all groups. All data are mean ± SEM of control and IR^Nkx2.1^ KO males. \**P* \< 0.05 control versus IR^Nkx2.1^ KO.](gr3){#fig3}

![**Defective behavioral responses in IR**^**Nkx2.1**^**KOs**. (**A**) Total distance traveled (left) and number of entries to the center (right), in each 5-minute bin during the open field test (OF); *n* ≥ 9 for all groups. (**B**) Number of marbles buried during a 20-min marble burying test (MB) at baseline and after stress; *n* ≥ 9 for all groups. (**C**) Stress-induced hyperthermia (SIH): body temperature at baseline and 60 min after stress; *n* ≥ 9 for all groups. (**D**) Latency to feed during novelty-supressed feeding (NSF) test; *n* ≥ 9 for all groups. (**E**) Time spent immobile during a 6-min forced-swim test (FST); *n* ≥ 9 for all groups. All data are mean ± SEM of control and IR^Nkx2.1^ KO males. \**P* \< 0.05 control versus IR^Nkx2.1^ KO.](gr4){#fig4}

![**Loss of InsR signals in Sim1 neurons did not lead to changes in stress response**. (**A**) Body weight of male IR^Sim1^ KO and controls; *n* ≥ 4 for all groups. (**B**) Fed glucose levels of male IR^Sim1^ KO and controls; *n* ≥ 4 for all groups. (**C**) Serum CORT levels during a restraint test (baseline, at the end of restraint, and 30 min after restraint; the period of restraint is indicated by a grey box) in adult males; *n* ≥ 4 for IR^Sim1^ KO and controls at all time points. (**D**) Baseline CORT levels of male IR^Sim1^ KO and controls; *n* ≥ 4 for all groups. (**E**) Baseline mRNA levels of *Crh*, *Avp*, *Gr*, *Pomc*, *Npy*, and *AgRP* in the hypothalamus of male IR^Sim1^ KO and controls; *n* ≥ 5 for all groups. (**F**) Baseline mRNA levels of *Pomc* and *Gr* in the pituitary of male IR^Sim1^ KO and controls; *n* ≥ 5 for all groups. All data are mean ± SEM of control and IR^Sim1^ KO males. \**P* \< 0.05 control versus IR^Sim1^ KO.](gr5){#fig5}

![**Loss of InsR signals in AgRP neurons resulted in decreased AVP release**. (**A**) Body weight of male IR^AgRP^ KO and controls; *n* ≥ 5 for all groups. (**B**) Fed glucose levels of male IR^AgRP^ KO and controls; *n* ≥ 5 for all groups. (**C**) Glucose-tolerance test of male IR^AgRP^ KO and controls. 2 mg/kg dextrose was injected i.p. at time 0. *n* ≥ 6 for all groups. (**D**) Baseline CORT levels of male IR^AgRP^ KO and controls; *n* ≥ 5 for all groups. (**E**) Serum CORT levels during a restraint test (baseline, at the end of restraint, and 30 min after restraint; the period of restraint is indicated by a grey box), and 30 min after restraint in adult males; *n* ≥ 5 for IR^AgRP^ KO and controls at all time points. (**F**) Baseline AVP protein levels in the median eminence of male IR^AgRP^ KO and controls. *n* ≥ 5 for all groups. (**G**) Baseline mRNA levels of *Crh*, *Avp*, *Gr*, *Pomc*, *Npy*, and *AgRP* in the hypothalamus of male IR^AgRP^ KO mice and controls; *n* ≥ 5 for all groups. (**H**) Baseline mRNA levels of *Pomc* and *Gr* in the pituitary of male IR^AgRP^ KO and controls; *n* ≥ 5 for all groups. All data are mean ± SEM of control and IR^AgRP^ KO males. \**P* \< 0.05 control versus IR^AgRP^ KO.](gr6){#fig6}

![**Components of HPA axis impacted by Cre lines in this study**. (**A**) *Nkx2.1-Cre*-mediated recombination is observed in most of the hypothalamus and posterior pituitary, but not in the PVH (or anterior pituitary). (**B**) *Sim1-Cre*-mediated recombination is observed in most neuronal subpopulations in the PVH, including AVP and CRH neurons. (**C**) *Agrp-Cre*-mediated recombination is restricted to a subpopulation of neurons in the ARH.](gr7){#fig7}
